Vimalson V. Monickam

Vimalson Monickam practices at Parker Jewish Institute in New Hyde Park, New York.

Vimalson Monickam's NPI, 1669556726, was assigned on October 25, 2006. Vimalson Monickam holds New York license 221615.

Vimalson Monickam's primary practice is Parker Jewish Institute, at 271-11 76th Ave, New Hyde Park, NY 11040 in Queens County. The practice phone is (718) 289-2100.

Vimalson Monickam's primary practice is Parker Jewish Institute in New Hyde Park, New York. Vimalson Monickam is also affiliated with Long Island Jewish Medical Center. The medical group on file is Parker Jewish Institute for Health Care and Rehabilitation. Dmand AI also links Vimalson Monickam to 1 more home health agency, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vimalson Monickam practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Vimalson Monickam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Vimalson Monickam is licensed in New York.

CMS data shows 712 Medicare services from Vimalson Monickam across 4 procedure codes in 2024, for 390 Medicare patients. Medicare paid $80,896 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 390 Medicare patients who saw Vimalson Monickam in 2024. The largest group is 85 and over, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vimalson Monickam's median patient age at 81, with 52% women.

In 2024, Vimalson Monickam wrote 8,027 Medicare Part D claims for 423 patients. 82% of them were for generic drugs. CMS names the drug for 7,284 of them, across 126 drugs with 11 or more claims each, at $378,811 in total drug cost. In 2023, CMS named 8,589 claims across 129 drugs.

Vimalson Monickam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 160 general payments to Vimalson Monickam from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,909.